Singapore grants interim approval for Moderna's bivalent Covid-19 booster vaccine

SINGAPORE - Singapore on Wednesday (Sept 14) granted interim authorisation for a bivalent Covid-19 booster vaccine made by Moderna, the government said in a statement.

The vaccine has been authorised for use as a booster shot in individuals aged 18 years and above who have received the primary series of Covid-19 vaccinations, the city-state's Health Sciences Authority said.

Moderna's bivalent vaccine contains mRNA designed to target two different coronavirus variants - the original variant from 2020 and the Omicron variant that was circulating widely last winter.

Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.